Literature DB >> 16958403

Long-term local control of recurrent adenoid cystic carcinoma in the parotid gland with radiotherapy and intraarterial infusion chemotherapy.

Koutarou Terashima1, Yoshiyuki Shioyama, Katsumasa Nakamura, Saiji Ohga, Satoshi Nomoto, Toshihiro Yamaguchi, Takashi Toba, Tadamasa Yoshitake, Hidetake Yabuuchi, Torahiko Nakashima, Hiromi Terashima, Hiroshi Honda.   

Abstract

We report a case of postoperative recurrence of adenoid cystic carcinoma in the left parotid gland treated with radiotherapy and arterial infusion chemotherapy. A 52-year-old woman had a history of surgical resection for an adenoid cystic carcinoma arising from the left parotid gland 25 years before. Despite two reoperations for local recurrence after the initial surgery, she had a third local recurrence in the remnant of the left parotid gland. The patient was treated with a concurrent combination of radiotherapy (60 Gy/30F) and intraarterial infusion chemotherapy with carboplatin (750 mg/30 days) from which she obtained a complete response. The patient has remained free of local progression 54 months after treatment. Radiotherapy and arterial infusion chemotherapy is effective treatment for local recurrence of adenoid cystic carcinoma in the head and neck.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958403     DOI: 10.1007/s11604-005-1567-4

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  13 in total

1.  Analysis of adenoid cystic carcinoma treated by radiotherapy.

Authors:  Y Hosokawa; K Ohmori; M Kaneko; M Yamasaki; M Ahmed; T Arimoto; G Irie
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1992-08

2.  Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation.

Authors:  Theresa A Gurney; David W Eisele; Vivian Weinberg; Ed Shin; Nancy Lee
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

3.  Clinical study of adenoid cystic carcinoma of the head and neck.

Authors:  D Takagi; S Fukuda; Y Furuta; K Yagi; A Homma; T Nagahashi; Y Inuyama
Journal:  Auris Nasus Larynx       Date:  2001-05       Impact factor: 1.863

4.  Radiation therapy in adenoid-cystic carcinoma.

Authors:  B Vikram; E W Strong; J P Shah; R H Spiro
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-02       Impact factor: 7.038

Review 5.  [The value of radiation therapy in the management of adenoid-cystic carcinoma of the head and neck].

Authors:  K F Kreitner; S Zapf; D Collo; J Kutzner
Journal:  Strahlenther Onkol       Date:  1988-08       Impact factor: 3.621

6.  Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.

Authors:  Jun-Etsu Mizoe; Hirohiko Tsujii; Tadashi Kamada; Yoshisuke Matsuoka; Hiroshi Tsuji; Yasuhiro Osaka; Azusa Hasegawa; Nobuharu Yamamoto; Satoshi Ebihara; Akiyoshi Konno
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-10-01       Impact factor: 7.038

7.  Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results.

Authors:  Marc W Münter; Christoph Thilmann; Holger Hof; Bernd Didinger; Bernhard Rhein; Simeon Nill; Wolfgang Schlegel; Michael Wannenmacher; Jürgen Debus
Journal:  Radiother Oncol       Date:  2003-03       Impact factor: 6.280

8.  Results of carbon ion radiotherapy in 152 patients.

Authors:  Daniela Schulz-Ertner; Anna Nikoghosyan; Christoph Thilmann; Thomas Haberer; Oliver Jäkel; Christian Karger; Gerhard Kraft; Michael Wannenmacher; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

9.  [Adenoid cystic carcinomas of the head and neck. Results of treatment with high-dosage radiotherapy].

Authors:  K F Kreitner; D Collo; S Zapf; J Kutzner
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1988-08

Review 10.  Adenoid cystic carcinoma of the head and neck: a review.

Authors:  Patrick J Bradley
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-04       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.